X
Get new exclusive access to healthcare business reports & breaking news
Biotech
![[Podcast] Are Stem Cells the Answer to COVID-19 long term damage to the human body?](https://healthcareweekly.com/wp-content/uploads/2020/07/shutterstock_1773310655.jpg)
Today’s guest is Dr. Anand Srivastava. He is the Co-founder, Chairman and Chief Scientific Officer of GIOSTAR. GIOSTAR ...
Sense Biodetection Limited recently announced a program launching the world’s first point-of-care, instrument-free, a molecular diagnostic test for ...
Biogen, a large biotech selected from among several companies in a competitive process, is partnering with Sangamo, a ...
On January 30th the Biotechnology Innovation Organization (BIO) released a comprehensive report on diversity and inclusion in the ...
Blueprint Medicines Corporation, a precision therapy company from Cambridge, Massachusetts, focused on genomically defined cancers, rare diseases and ...
In this episode, Codrin Arsene is joined by Kevin Costa. He is the Co-Founder and Chief Scientific Officer ...
New data from an independent study has confirmed that Proteus’ ingestible pill and sensor system has multiple benefits ...
Pretomanid, developed by the non-profit TB Alliance, has received U.S. approval for people with XDR-TB or treatment-intolerant/non-responsive MDR-TB. ...
Researchers could be on the verge of finding a cure for HIV after being able to use gene ...
